GUBRA.CO vs. ZEAL.CO

Last updated Apr 3, 2026

Compare and contrast key facts about Gubra A/S (GUBRA.CO) and Zealand Pharma A/S (ZEAL.CO).

Performance

GUBRA.CO vs. ZEAL.CO - Performance Comparison

The chart below illustrates the hypothetical performance of a DKK 10,000 investment in Gubra A/S (GUBRA.CO) and Zealand Pharma A/S (ZEAL.CO). The values are adjusted to include any dividend payments, if applicable.

GUBRA.CO vs. ZEAL.CO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
GUBRA.CO Gubra A/S	-29.62%	-6.15%	399.20%	13.64%
ZEAL.CO Zealand Pharma A/S	-36.11%	-34.81%	91.72%	72.30%

Returns By Period

In the year-to-date period, GUBRA.CO achieves a -29.62% return, which is significantly higher than ZEAL.CO's -36.11% return.

GUBRA.CO

• 1D: 2.59%
• 1M: -5.40%
• YTD: -29.62%
• 6M: -15.62%
• 1Y: -3.70%
• 3Y*: —
• 5Y*: —
• 10Y*: —

ZEAL.CO

• 1D: 1.02%
• 1M: -16.41%
• YTD: -36.11%
• 6M: -40.97%
• 1Y: -35.97%
• 3Y*: 11.53%
• 5Y*: 8.24%
• 10Y*: 8.57%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

GUBRA.CO vs. ZEAL.CO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GUBRA.CO

GUBRA.CO Risk / Return Rank: 33
GUBRA.CO Sharpe Ratio Rank: 33
GUBRA.CO Sortino Ratio Rank: 33
GUBRA.CO Omega Ratio Rank: 33
GUBRA.CO Calmar Ratio Rank: 34
GUBRA.CO Martin Ratio Rank: 33

ZEAL.CO

ZEAL.CO Risk / Return Rank: 15
ZEAL.CO Sharpe Ratio Rank: 16
ZEAL.CO Sortino Ratio Rank: 20
ZEAL.CO Omega Ratio Rank: 20
ZEAL.CO Calmar Ratio Rank: 12
ZEAL.CO Martin Ratio Rank: 5

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GUBRA.CO vs. ZEAL.CO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Gubra A/S (GUBRA.CO) and Zealand Pharma A/S (ZEAL.CO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	GUBRA.CO	ZEAL.CO	Difference
Sharpe ratio Return per unit of total volatility	-0.14	-0.55	+0.41
Sortino ratio Return per unit of downside risk	0.21	-0.40	+0.62
Omega ratio Gain probability vs. loss probability	1.02	0.94	+0.08
Calmar ratio Return relative to maximum drawdown	-0.17	-0.77	+0.59
Martin ratio Return relative to average drawdown	-0.37	-1.65	+1.28
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

GUBRA.CO vs. ZEAL.CO - Sharpe Ratio Comparison

The current GUBRA.CO Sharpe Ratio is -0.14, which is higher than the ZEAL.CO Sharpe Ratio of -0.55. The chart below compares the historical Sharpe Ratios of GUBRA.CO and ZEAL.CO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	GUBRA.CO	ZEAL.CO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.14	-0.55	+0.41
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.14	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.17	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.82	0.18	+0.64

Correlation

The correlation between GUBRA.CO and ZEAL.CO is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

GUBRA.CO vs. ZEAL.CO - Dividend Comparison

GUBRA.CO's dividend yield for the trailing twelve months is around 16.80%, while ZEAL.CO has not paid dividends to shareholders.

	TTM	2025
GUBRA.CO Gubra A/S	16.80%	11.83%
ZEAL.CO Zealand Pharma A/S	0.00%	0.00%

Drawdowns

GUBRA.CO vs. ZEAL.CO - Drawdown Comparison

The maximum GUBRA.CO drawdown since its inception was -52.03%, smaller than the maximum ZEAL.CO drawdown of -75.53%. Use the drawdown chart below to compare losses from any high point for GUBRA.CO and ZEAL.CO.

Drawdown Indicators

	GUBRA.CO	ZEAL.CO	Difference
Max Drawdown Largest peak-to-trough decline	-52.03%	-75.53%	+23.50%
Max Drawdown (1Y) Largest decline over 1 year	-38.99%	-56.96%	+17.97%
Max Drawdown (5Y) Largest decline over 5 years	—	-75.38%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-75.53%	—
Current Drawdown Current decline from peak	-43.39%	-68.76%	+25.37%
Average Drawdown Average peak-to-trough decline	-20.58%	-29.52%	+8.94%
Ulcer Index Depth and duration of drawdowns from previous peaks	18.26%	26.76%	-8.50%

Volatility

GUBRA.CO vs. ZEAL.CO - Volatility Comparison

The current volatility for Gubra A/S (GUBRA.CO) is 14.14%, while Zealand Pharma A/S (ZEAL.CO) has a volatility of 48.77%. This indicates that GUBRA.CO experiences smaller price fluctuations and is considered to be less risky than ZEAL.CO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	GUBRA.CO	ZEAL.CO	Difference
Volatility (1M) Calculated over the trailing 1-month period	14.14%	48.77%	-34.63%
Volatility (6M) Calculated over the trailing 6-month period	41.98%	58.53%	-16.55%
Volatility (1Y) Calculated over the trailing 1-year period	58.47%	66.35%	-7.88%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	68.30%	59.85%	+8.45%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	68.30%	52.09%	+16.21%

Financials